2018年至2021年沙特阿拉伯贾赞的哈特死亡事件
Ghassan Shaikhain1, Mohammed Gaballah2, Ahmad Alhazmi2
1Forensic Toxicology Services, Forensic Medical Center, Ministry of Health, Jazan 45142, Saudi Arabia.
Toxics
|June 27, 2023
概括
在沙特阿拉伯,涉及卡特的死亡人数正在增加. 这项研究确定了死后样本中甲和甲的参考度,有助于对有关卡特的死亡进行法医调查.
科学领域:
- 法医毒理学 法医毒理学
- 验尸调查 验尸调查 验尸调查
- 药物滥用和死亡率分析
背景情况:
- 解释涉及卡特 (Catha edulis) 的死亡事故是由于缺乏其活性成分,甲和甲在死后组织中的确定的基准度而受到阻碍.
- 卡特的消费在某些地区普遍存在,因此需要更好地了解其在死亡率中的作用.
研究的目的:
- 调查与沙特阿拉伯卡特使用相关的死亡事故的尸检结果和毒理学结果.
- 为了确定各种死后样本中甲和甲的参考度范围.
- 确定卡特对整体死亡事故的贡献及其与其他物质的关联.
主要方法:
- 沙特阿拉伯贾赞地区法医医学中心调查的651起死亡病例 (2018-2021) 的回顾性分析.
- 对死后样本 (血液,尿液,大脑,肝脏,脏,胃) 进行毒理分析,以检测甲和甲.
- 对尸检结果,死亡原因和死亡方式的审查,对于检测卡特成分阳性的病例.
主要成果:
- 在651例病例中,有30例 (4.6%) 呈阴和/或阴阳性检测.
- 与卡特有关的死亡人数从2018-2019年的3%增加到2021年的9%.
- 已确定的参考范围:血液 (甲氨18-218 ng/mL,甲氨222-843 ng/mL),大脑 (69-682 ng/mL),肝脏 (64-635 ng/mL),脏 (43-758 ng/mL).
- 杀人是最常见的死亡原因 (77%) 在卡特死亡事故中.
- 43%的阳性病例还涉及其他药物,主要是安非他林.
结论:
- 这项研究提供了死后样本中甲和甲的关键基准度,有助于法医毒理学家解释与甲相关的死亡事故.
- 与卡特相关的死亡人数不断增加的趋势凸显了持续监测和研究的必要性.
- 对毒理学和尸检发现的进一步调查对于准确评估卡特在刑事案件和死亡率中的作用至关重要.
相关概念视频
01:14Prevention of Further Absorption of Poison
866
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
866
01:11Hazard Rate
139
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
139
01:12Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:19Pharmacovigilance
908
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
908
01:30Overview of Cell Death
7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K